| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.77B | 132.19B | 143.12B | 147.26B | 170.12B | 111.94B |
| Gross Profit | 9.56B | 6.49B | 4.86B | 11.29B | 12.77B | 3.38B |
| EBITDA | 11.50B | 9.76B | 5.99B | 12.37B | 16.91B | 3.95B |
| Net Income | 4.12B | 4.40B | 2.12B | 7.00B | 11.02B | 1.31B |
Balance Sheet | ||||||
| Total Assets | 84.08B | 73.68B | 72.58B | 75.50B | 76.44B | 55.59B |
| Cash, Cash Equivalents and Short-Term Investments | 5.15B | 1.12B | 1.74B | 3.32B | 6.13B | 3.15B |
| Total Debt | 27.12B | 22.88B | 20.06B | 19.36B | 17.19B | 14.74B |
| Total Liabilities | 54.40B | 43.44B | 44.12B | 43.85B | 42.34B | 33.96B |
| Stockholders Equity | 28.53B | 29.09B | 27.41B | 30.58B | 29.49B | 19.17B |
Cash Flow | ||||||
| Free Cash Flow | 119.00M | 2.73B | 2.33B | 4.61B | 8.62B | 4.16B |
| Operating Cash Flow | 2.51B | 4.96B | 4.19B | 7.03B | 10.81B | 6.02B |
| Investing Cash Flow | -4.16B | -1.97B | -2.46B | -5.86B | -1.49B | -1.87B |
| Financing Cash Flow | 5.30B | -3.67B | -3.31B | -4.03B | -6.39B | -3.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $12.62B | 4.35 | 13.11% | 4.26% | -1.08% | ― | |
74 Outperform | $14.58B | 3.45 | 16.51% | 6.88% | 37.27% | -29.09% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
65 Neutral | $74.45B | 35.24 | 27.33% | 2.24% | -1.29% | 114.86% | |
63 Neutral | $74.45B | 14.57 | 17.63% | 2.74% | -2.53% | 385.02% | |
57 Neutral | $5.00B | 7.04 | 8.35% | 4.14% | -4.33% | ― | |
56 Neutral | $70.64B | 88.46 | 14.72% | 3.68% | -1.33% | 130.72% |